During the past decade, Fahd Bin Jassem Dialysis Centre conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Fahd Bin Jassem Dialysis Centre" are "Anemia of End Stage Renal Disease" (1 trials) and "Hemodialysis, Tunneled Catheter, Qatar" (1 trials). Many other conditions were trialed in "Fahd Bin Jassem Dialysis Centre" in a lesser frequency.

Most popular intervention types in "Fahd Bin Jassem Dialysis Centre" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "(TauroLock Hep500)" (1 trials), "Darbepoetin alfa" (1 trials), "Epoetin alpha or beta (Epoetin group)" (1 trials), "Methoxy polyethylene glycol-epoetin beta" (1 trials) and "TauroLock U 25000" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fahd Bin Jassem Dialysis Centre" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Fahd Bin Jassem Dialysis Centre". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Fahd Bin Jassem Dialysis Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fahd Bin Jassem Dialysis Centre, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".